profit from every $100 of sales.
$0$100
Vicarious Surgical
$0.02+0.00% today
-99.0% in 1 year
1-year low $0.011-year high $2.06
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Vicarious Surgical sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$50.2 million of profit last year.
SalesProfit
Vicarious Surgical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Vicarious Surgical | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Vicarious Surgical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -80 | -81 | -67 | -51 | |
| 6 | -69 | -64 | -50 | |
| 5 | -71 | -63 | -50 | |
| 1.20 | -14.60 | -10.74 | -8.19 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 140 | 120 | 68 | 20 |
| Cash | 116 | 53 | 10 | 3 |
| Total debt | 16 | 15 | 14 | 8 |
| Total liabilities | 29 | 22 | 21 | 10 |
| 111 | 98 | 47 | 10 | |
| 4 | 5 | 6 | 6 | |
| 3.3% | -49.8% | -86.9% | -228.4% | |
| 4.6% | -72.5% | -135.4% | -509.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -61 | -62 | -50 | -45 | |
| 5 | 2 | 0 | 0 | |
| -67 | -64 | -50 | -45 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 12 | 13 | 12 | 8 |
Valuation
- –
- –
- –
- 1.3×
- –
- –
- –
- -31,696.7%
- -35,184.1%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -411.0%
- -98.0%
- -333.2%
- -334.6%
- -462.5%
- –
Growth
- –
- –
- +9.8%
- –
- +16.5%
Financial health
- -0.1×
- 1.91
- 54.2%
- –
- 1.54
- 1.54
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 20%of 884
What analysts expect
- Average price target
- $8.75
- Range
- $7.00 – $10.50
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | -1.03 | -1.20 | +14.2% |
| Mar 9, 2026 | -1.65 | -1.37 | −20.4% |
| Nov 12, 2025 | -1.91 | -2.37 | +19.4% |
| Aug 12, 2025 | -2.23 | -2.61 | +14.6% |
| May 12, 2025 | -2.58 | -2.61 | +1.1% |
| Mar 17, 2025 | -2.43 | -2.69 | +9.7% |
| Nov 12, 2024 | -2.87 | -2.61 | −10.0% |
| Aug 12, 2024 | -2.86 | -2.98 | +4.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/6Passes 0 of 6. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
32No pass
Benjamin Graham
41No pass
Philip Fisher
34No pass
Peter Lynch
28No pass
Joel Greenblatt
–Not enough data
Charlie Munger
22No pass
Terry Smith
26No pass
Questions about Vicarious Surgical
Is Vicarious Surgical a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 6 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Vicarious Surgical AI analysis
What does Vicarious Surgical do?
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. It is in Medical - Devices.
Does Vicarious Surgical pay a dividend?
No. Vicarious Surgical does not pay a dividend at the moment.
Is Vicarious Surgical stock halal?
No. Vicarious Surgical does not pass our halal screen: its debt is 5,462% of its market value, at or above the 33% limit. How we check
How has Vicarious Surgical stock done over the past year?
Down 99.0% over the past twelve months, to $0.02. It traded between $0.01 and $2.06 and is 99.0% below its high.
Who are Vicarious Surgical's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Vicarious Surgical's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.